Hanmi Pharmaceutical acquires Canada's Aptoz... Recovery of leukemia treatment rights

(Seoul = Yonhap News) Reporter Park Sang-hyun = Hanmi Pharmaceutical [128940] handed over the development and commercialization rights to 'Tuspetinib', a new drug candidate for acute myeloid leukemia, to Canada...